Hematological Oncology : Impact Factor & More
eISSN: 1099-1069pISSN: 0278-0232
Share this on:
Key Metrics
CiteScore 
5.3
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Oncology
SNIP
1.04
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Hematological Oncology
Hematological Oncology Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1983 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Hematological Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Hematological Oncology
Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy.
- 1 Sep 2026
- Hematological oncology
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell Lymphoma.
- 1 Sep 2026
- Hematological oncology
Studying Chronic Lymphocytic Leukemia Microenvironment in the Multi Omics Era.
- 1 Sep 2026
- Hematological oncology
Targeting a CDH1-TK1-dependent DNA Synthesis Pathway Overcomes Chemoresistance in Acute Myeloid Leukemia.
- 1 Sep 2026
- Hematological oncology
Defining a Therapeutic Window for Venetoclax in Post\u2010Transplant Maintenance Therapy for High\u2010Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes
- 6 Aug 2026
- Hematological Oncology
DNA Replication Stress\u2010Induced Transcriptome of Human Burkitt's Lymphoma Identifies Reciprocal Regulation Between MBD1 and BCL6 During Germinal Center\u2010Derived B\u2010Lymphomagenesis
- 6 Aug 2026
- Hematological Oncology
Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy.
- 1 Sep 2026
- Hematological oncology
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell Lymphoma.
- 1 Sep 2026
- Hematological oncology
Studying Chronic Lymphocytic Leukemia Microenvironment in the Multi Omics Era.
- 1 Sep 2026
- Hematological oncology
Targeting a CDH1-TK1-dependent DNA Synthesis Pathway Overcomes Chemoresistance in Acute Myeloid Leukemia.
- 1 Sep 2026
- Hematological oncology
Defining a Therapeutic Window for Venetoclax in Post\u2010Transplant Maintenance Therapy for High\u2010Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes
- 6 Aug 2026
- Hematological Oncology
DNA Replication Stress\u2010Induced Transcriptome of Human Burkitt's Lymphoma Identifies Reciprocal Regulation Between MBD1 and BCL6 During Germinal Center\u2010Derived B\u2010Lymphomagenesis
- 6 Aug 2026
- Hematological Oncology
FAQs on Hematological Oncology
How long has Hematological Oncology been actively publishing? 
What is the publishing frequency of Hematological Oncology?
How many articles did Hematological Oncology publish last year?
What is the eISSN & pISSN for Hematological Oncology?
What is Citescore for Hematological Oncology?
What is SNIP score for Hematological Oncology?
What is the SJR for Hematological Oncology?
Who is the publisher of Hematological Oncology?
